KCNE4 and neoplasm: CCL17 is a ligand for CCR4, which activates CCR4-expressing Th2 cells and regulatory T-cells (Tregs) and suppresses effector cells; KCNE4 may contribute to tumor cell survival through activation of Tregs via increasing CCL17 production.